img

Global Gene Therapy Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gene Therapy Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global Gene Therapy Drugs market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Neuromuscular Disease accounting for % of the Gene Therapy Drugs global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Hospital segment is altered to an % CAGR throughout this forecast period.
The global key companies of Gene Therapy Drugs include F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., Ultragenyx Pharmaceutical,Inc., Applied Genetic Technologies Corp, Audentes Therapeutics, BioMarin Pharmaceutical, Bluebird Bio and Nightstar Therapeutics, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States Gene Therapy Drugs market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe Gene Therapy Drugs landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Gene Therapy Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Gene Therapy Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Gene Therapy Drugs market. Readers of the report can become informed about current and future trends of the global Gene Therapy Drugs market and how they will impact market growth during the forecast period.



By Company


F. Hoffmann-La Roche AG
Novartis International AG
Gilead Sciences, Inc.
Ultragenyx Pharmaceutical,Inc.
Applied Genetic Technologies Corp
Audentes Therapeutics
BioMarin Pharmaceutical
Bluebird Bio
Nightstar Therapeutics
Sangamo Therapeutics
Spark Therapeutics
uniQure
VBL Therapeutics
Voyager Therapeutics
Segment by Type
Neuromuscular Disease
Genetic Disease
Other

Segment by Application


Hospital
Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Gene Therapy Drugs in global and regional level.
Chapter 3Detailed analysis of Gene Therapy Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy Drugs revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Neuromuscular Disease
1.2.3 Genetic Disease
1.2.4 Other
1.3 Market by Application
1.3.1 Global Gene Therapy Drugs Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Gene Therapy Drugs Market Size (2018-2034)
2.2 Gene Therapy Drugs Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global Gene Therapy Drugs Market Size by Region (2018-2024)
2.4 Global Gene Therapy Drugs Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Gene Therapy Drugs Countries Ranking by Market Size
3 Gene Therapy Drugs Competitive by Company
3.1 Global Gene Therapy Drugs Revenue by Players
3.1.1 Global Gene Therapy Drugs Revenue by Players (2018-2024)
3.1.2 Global Gene Therapy Drugs Market Share by Players (2018-2024)
3.2 Global Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Gene Therapy Drugs Revenue
3.4 Global Gene Therapy Drugs Market Concentration Ratio
3.4.1 Global Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Drugs Revenue in 2022
3.5 Global Key Players of Gene Therapy Drugs Head office and Area Served
3.6 Global Key Players of Gene Therapy Drugs, Product and Application
3.7 Global Key Players of Gene Therapy Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Gene Therapy Drugs Breakdown Data by Type
4.1 Global Gene Therapy Drugs Historic Revenue by Type (2018-2024)
4.2 Global Gene Therapy Drugs Forecasted Revenue by Type (2024-2034)
5 Global Gene Therapy Drugs Breakdown Data by Application
5.1 Global Gene Therapy Drugs Historic Market Size by Application (2018-2024)
5.2 Global Gene Therapy Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Gene Therapy Drugs Revenue by Company (2021-2024)
6.2 North America Gene Therapy Drugs Revenue by Type (2018-2034)
6.3 North America Gene Therapy Drugs Revenue by Application (2018-2034)
6.4 North America Gene Therapy Drugs Revenue by Country (2018-2034)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Gene Therapy Drugs Revenue by Company (2021-2024)
7.2 Europe Gene Therapy Drugs Revenue by Type (2018-2034)
7.3 Europe Gene Therapy Drugs Revenue by Application (2018-2034)
7.4 Europe Gene Therapy Drugs Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Gene Therapy Drugs Revenue by Company (2021-2024)
8.2 Asia Pacific Gene Therapy Drugs Revenue by Type (2018-2034)
8.3 Asia Pacific Gene Therapy Drugs Revenue by Application (2018-2034)
8.4 Asia Pacific Gene Therapy Drugs Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Gene Therapy Drugs Revenue by Company (2021-2024)
9.2 Latin America Gene Therapy Drugs Revenue by Type (2018-2034)
9.3 Latin America Gene Therapy Drugs Revenue by Application (2018-2034)
9.4 Latin America Gene Therapy Drugs Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gene Therapy Drugs Revenue by Company (2021-2024)
10.2 Middle East and Africa Gene Therapy Drugs Revenue by Type (2018-2034)
10.3 Middle East and Africa Gene Therapy Drugs Revenue by Application (2018-2034)
10.4 Middle East and Africa Gene Therapy Drugs Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 F. Hoffmann-La Roche AG
11.1.1 F. Hoffmann-La Roche AG Company Details
11.1.2 F. Hoffmann-La Roche AG Business Overview
11.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Products and Services
11.1.4 F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.1.5 F. Hoffmann-La Roche AG Gene Therapy Drugs SWOT Analysis
11.1.6 F. Hoffmann-La Roche AG Recent Development
11.2 Novartis International AG
11.2.1 Novartis International AG Company Details
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Gene Therapy Drugs Products and Services
11.2.4 Novartis International AG Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.2.5 Novartis International AG Gene Therapy Drugs SWOT Analysis
11.2.6 Novartis International AG Recent Development
11.3 Gilead Sciences, Inc.
11.3.1 Gilead Sciences, Inc. Company Details
11.3.2 Gilead Sciences, Inc. Business Overview
11.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Products and Services
11.3.4 Gilead Sciences, Inc. Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.3.5 Gilead Sciences, Inc. Gene Therapy Drugs SWOT Analysis
11.3.6 Gilead Sciences, Inc. Recent Development
11.4 Ultragenyx Pharmaceutical,Inc.
11.4.1 Ultragenyx Pharmaceutical,Inc. Company Details
11.4.2 Ultragenyx Pharmaceutical,Inc. Business Overview
11.4.3 Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Products and Services
11.4.4 Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.4.5 Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs SWOT Analysis
11.4.6 Ultragenyx Pharmaceutical,Inc. Recent Development
11.5 Applied Genetic Technologies Corp
11.5.1 Applied Genetic Technologies Corp Company Details
11.5.2 Applied Genetic Technologies Corp Business Overview
11.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Products and Services
11.5.4 Applied Genetic Technologies Corp Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.5.5 Applied Genetic Technologies Corp Gene Therapy Drugs SWOT Analysis
11.5.6 Applied Genetic Technologies Corp Recent Development
11.6 Audentes Therapeutics
11.6.1 Audentes Therapeutics Company Details
11.6.2 Audentes Therapeutics Business Overview
11.6.3 Audentes Therapeutics Gene Therapy Drugs Products and Services
11.6.4 Audentes Therapeutics Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.6.5 Audentes Therapeutics Gene Therapy Drugs SWOT Analysis
11.6.6 Audentes Therapeutics Recent Development
11.7 BioMarin Pharmaceutical
11.7.1 BioMarin Pharmaceutical Company Details
11.7.2 BioMarin Pharmaceutical Business Overview
11.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Products and Services
11.7.4 BioMarin Pharmaceutical Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.7.5 BioMarin Pharmaceutical Gene Therapy Drugs SWOT Analysis
11.7.6 BioMarin Pharmaceutical Recent Development
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Details
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Gene Therapy Drugs Products and Services
11.8.4 Bluebird Bio Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.8.5 Bluebird Bio Gene Therapy Drugs SWOT Analysis
11.8.6 Bluebird Bio Recent Development
11.9 Nightstar Therapeutics
11.9.1 Nightstar Therapeutics Company Details
11.9.2 Nightstar Therapeutics Business Overview
11.9.3 Nightstar Therapeutics Gene Therapy Drugs Products and Services
11.9.4 Nightstar Therapeutics Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.9.5 Nightstar Therapeutics Gene Therapy Drugs SWOT Analysis
11.9.6 Nightstar Therapeutics Recent Development
11.10 Sangamo Therapeutics
11.10.1 Sangamo Therapeutics Company Details
11.10.2 Sangamo Therapeutics Business Overview
11.10.3 Sangamo Therapeutics Gene Therapy Drugs Products and Services
11.10.4 Sangamo Therapeutics Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.10.5 Sangamo Therapeutics Gene Therapy Drugs SWOT Analysis
11.10.6 Sangamo Therapeutics Recent Development
11.11 Spark Therapeutics
11.11.1 Spark Therapeutics Company Details
11.11.2 Spark Therapeutics Business Overview
11.11.3 Spark Therapeutics Gene Therapy Drugs Products and Services
11.11.4 Spark Therapeutics Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.11.5 Spark Therapeutics Recent Development
11.12 uniQure
11.12.1 uniQure Company Details
11.12.2 uniQure Business Overview
11.12.3 uniQure Gene Therapy Drugs Products and Services
11.12.4 uniQure Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.12.5 uniQure Recent Development
11.13 VBL Therapeutics
11.13.1 VBL Therapeutics Company Details
11.13.2 VBL Therapeutics Business Overview
11.13.3 VBL Therapeutics Gene Therapy Drugs Products and Services
11.13.4 VBL Therapeutics Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.13.5 VBL Therapeutics Recent Development
11.14 Voyager Therapeutics
11.14.1 Voyager Therapeutics Company Details
11.14.2 Voyager Therapeutics Business Overview
11.14.3 Voyager Therapeutics Gene Therapy Drugs Products and Services
11.14.4 Voyager Therapeutics Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024)
11.14.5 Voyager Therapeutics Recent Development
12 Gene Therapy Drugs Market Dynamics
12.1 Gene Therapy Drugs Industry Trends
12.2 Gene Therapy Drugs Market Drivers
12.3 Gene Therapy Drugs Market Challenges
12.4 Gene Therapy Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Gene Therapy Drugs Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Neuromuscular Disease
Table 3. Key Players of Genetic Disease
Table 4. Key Players of Other
Table 5. Global Gene Therapy Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 6. Global Gene Therapy Drugs Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 7. Global Gene Therapy Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Gene Therapy Drugs Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 9. Global Gene Therapy Drugs Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 10. Global Gene Therapy Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 11. Global Gene Therapy Drugs Market Share by Players (2018-2024)
Table 12. Global Top Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Drugs as of 2022)
Table 13. Ranking of Global Top Gene Therapy Drugs Companies by Revenue (US$ Million) in 2022
Table 14. Global 5 Largest Players Market Share by Gene Therapy Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 15. Global Key Players of Gene Therapy Drugs, Headquarters and Area Served
Table 16. Global Key Players of Gene Therapy Drugs, Product and Application
Table 17. Global Key Players of Gene Therapy Drugs, Date of Enter into This Industry
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Gene Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 20. Global Gene Therapy Drugs Revenue Market Share by Type (2018-2024)
Table 21. Global Gene Therapy Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 22. Global Gene Therapy Drugs Revenue Market Share by Type (2024-2034)
Table 23. Global Gene Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 24. Global Gene Therapy Drugs Revenue Market Share by Application (2018-2024)
Table 25. Global Gene Therapy Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 26. Global Gene Therapy Drugs Revenue Market Share by Application (2024-2034)
Table 27. North America Gene Therapy Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 28. North America Gene Therapy Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 29. North America Gene Therapy Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 30. North America Gene Therapy Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 31. North America Gene Therapy Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 32. North America Gene Therapy Drugs Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 33. North America Gene Therapy Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. North America Gene Therapy Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Europe Gene Therapy Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 36. Europe Gene Therapy Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 37. Europe Gene Therapy Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 38. Europe Gene Therapy Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 39. Europe Gene Therapy Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 40. Europe Gene Therapy Drugs Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 41. Europe Gene Therapy Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 42. Europe Gene Therapy Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 43. Asia Pacific Gene Therapy Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 44. Asia Pacific Gene Therapy Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 45. Asia Pacific Gene Therapy Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 46. Asia Pacific Gene Therapy Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 47. Asia Pacific Gene Therapy Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 48. Asia-Pacific Gene Therapy Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 49. Asia Pacific Gene Therapy Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 50. Asia Pacific Gene Therapy Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 51. Latin America Gene Therapy Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 52. Latin America Gene Therapy Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 53. Latin America Gene Therapy Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 54. Latin America Gene Therapy Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 55. Latin America Gene Therapy Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 56. Latin America Gene Therapy Drugs Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 57. Latin America Gene Therapy Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 58. Latin America Gene Therapy Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 59. Middle East and Africa Gene Therapy Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 60. Middle East and Africa Gene Therapy Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 61. Middle East and Africa Gene Therapy Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 62. Middle East and Africa Gene Therapy Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 63. Middle East and Africa Gene Therapy Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 64. Middle East and Africa Gene Therapy Drugs Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 65. Middle East and Africa Gene Therapy Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Gene Therapy Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 67. F. Hoffmann-La Roche AG Company Details
Table 68. F. Hoffmann-La Roche AG Business Overview
Table 69. F. Hoffmann-La Roche AG Gene Therapy Drugs Product and Services
Table 70. F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 71. F. Hoffmann-La Roche AG Gene Therapy Drugs SWOT Analysis
Table 72. F. Hoffmann-La Roche AG Recent Development
Table 73. Novartis International AG Company Details
Table 74. Novartis International AG Business Overview
Table 75. Novartis International AG Gene Therapy Drugs Product and Services
Table 76. Novartis International AG Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 77. Novartis International AG Gene Therapy Drugs SWOT Analysis
Table 78. Novartis International AG Recent Development
Table 79. Gilead Sciences, Inc. Company Details
Table 80. Gilead Sciences, Inc. Business Overview
Table 81. Gilead Sciences, Inc. Gene Therapy Drugs Product and Services
Table 82. Gilead Sciences, Inc. Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 83. Gilead Sciences, Inc. Gene Therapy Drugs SWOT Analysis
Table 84. Gilead Sciences, Inc. Recent Development
Table 85. Ultragenyx Pharmaceutical,Inc. Company Details
Table 86. Ultragenyx Pharmaceutical,Inc. Business Overview
Table 87. Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Product and Services
Table 88. Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 89. Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs SWOT Analysis
Table 90. Ultragenyx Pharmaceutical,Inc. Recent Development
Table 91. Applied Genetic Technologies Corp Company Details
Table 92. Applied Genetic Technologies Corp Business Overview
Table 93. Applied Genetic Technologies Corp Gene Therapy Drugs Product and Services
Table 94. Applied Genetic Technologies Corp Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 95. Applied Genetic Technologies Corp Gene Therapy Drugs SWOT Analysis
Table 96. Applied Genetic Technologies Corp Recent Development
Table 97. Audentes Therapeutics Company Details
Table 98. Audentes Therapeutics Business Overview
Table 99. Audentes Therapeutics Gene Therapy Drugs Product and Services
Table 100. Audentes Therapeutics Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 101. Audentes Therapeutics Gene Therapy Drugs SWOT Analysis
Table 102. Audentes Therapeutics Recent Development
Table 103. BioMarin Pharmaceutical Company Details
Table 104. BioMarin Pharmaceutical Business Overview
Table 105. BioMarin Pharmaceutical Gene Therapy Drugs Product and Services
Table 106. BioMarin Pharmaceutical Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 107. BioMarin Pharmaceutical Gene Therapy Drugs SWOT Analysis
Table 108. BioMarin Pharmaceutical Recent Development
Table 109. Bluebird Bio Company Details
Table 110. Bluebird Bio Business Overview
Table 111. Bluebird Bio Gene Therapy Drugs Product and Services
Table 112. Bluebird Bio Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 113. Bluebird Bio Gene Therapy Drugs SWOT Analysis
Table 114. Bluebird Bio Recent Development
Table 115. Nightstar Therapeutics Company Details
Table 116. Nightstar Therapeutics Business Overview
Table 117. Nightstar Therapeutics Gene Therapy Drugs Product and Services
Table 118. Nightstar Therapeutics Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 119. Nightstar Therapeutics Gene Therapy Drugs SWOT Analysis
Table 120. Nightstar Therapeutics Recent Development
Table 121. Sangamo Therapeutics Company Details
Table 122. Sangamo Therapeutics Business Overview
Table 123. Sangamo Therapeutics Gene Therapy Drugs Product and Services
Table 124. Sangamo Therapeutics Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 125. Sangamo Therapeutics Gene Therapy Drugs SWOT Analysis
Table 126. Sangamo Therapeutics Recent Development
Table 127. Spark Therapeutics Company Details
Table 128. Spark Therapeutics Business Overview
Table 129. Spark Therapeutics Gene Therapy Drugs Product and Services
Table 130. Spark Therapeutics Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 131. Spark Therapeutics Recent Development
Table 132. uniQure Company Details
Table 133. uniQure Business Overview
Table 134. uniQure Gene Therapy Drugs Product and Services
Table 135. uniQure Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 136. uniQure Recent Development
Table 137. VBL Therapeutics Company Details
Table 138. VBL Therapeutics Business Overview
Table 139. VBL Therapeutics Gene Therapy Drugs Product and Services
Table 140. VBL Therapeutics Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 141. VBL Therapeutics Recent Development
Table 142. Voyager Therapeutics Company Details
Table 143. Voyager Therapeutics Business Overview
Table 144. Voyager Therapeutics Gene Therapy Drugs Product and Services
Table 145. Voyager Therapeutics Gene Therapy Drugs Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 146. Voyager Therapeutics Recent Development
Table 147. Gene Therapy Drugs Market Trends
Table 148. Gene Therapy Drugs Market Drivers
Table 149. Gene Therapy Drugs Market Challenges
Table 150. Gene Therapy Drugs Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Therapy Drugs Product Picture
Figure 2. Global Gene Therapy Drugs Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global Gene Therapy Drugs Market Share by Type: 2022 VS 2034
Figure 4. Neuromuscular Disease Features
Figure 5. Genetic Disease Features
Figure 6. Other Features
Figure 7. Global Gene Therapy Drugs Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 8. Global Gene Therapy Drugs Market Share by Application: 2022 VS 2034
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Gene Therapy Drugs Report Years Considered
Figure 12. Global Gene Therapy Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Gene Therapy Drugs Market Size 2018-2034 (US$ Million)
Figure 14. Global Gene Therapy Drugs Market Size Market Share by Region: 2022 VS 2034
Figure 15. Global Gene Therapy Drugs Revenue Market Share by Region in 2018 VS 2022
Figure 16. Global Gene Therapy Drugs Revenue Market Share Forecast by Region (2024-2034)
Figure 17. Global Top 10 Gene Therapy Drugs Countries Ranking by Market Size (US$ Million) in 2022
Figure 18. Global Gene Therapy Drugs Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 19. Global Gene Therapy Drugs Market Share by Players in 2022
Figure 20. Global Top Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Drugs as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Gene Therapy Drugs Revenue in 2022
Figure 22. North America Gene Therapy Drugs Revenue Market Share by Company in 2022
Figure 23. North America Gene Therapy Drugs Revenue Market Share by Type (2018-2034)
Figure 24. North America Gene Therapy Drugs Revenue Market Share by Application (2018-2034)
Figure 25. North America Gene Therapy Drugs Revenue Share by Country (2018-2034)
Figure 26. United States Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 27. Canada Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 28. Europe Gene Therapy Drugs Revenue Market Share by Company in 2022
Figure 29. Europe Gene Therapy Drugs Revenue Market Share by Type (2018-2034)
Figure 30. Europe Gene Therapy Drugs Revenue Market Share by Application (2018-2034)
Figure 31. Europe Gene Therapy Drugs Revenue Share by Country (2018-2034)
Figure 32. Germany Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 33. France Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 34. U.K. Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 35. Italy Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 36. Russia Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 37. Asia Pacific Gene Therapy Drugs Revenue Market Share by Company in 2022
Figure 38. Asia Pacific Gene Therapy Drugs Revenue Market Share by Type (2018-2034)
Figure 39. Asia Pacific Gene Therapy Drugs Revenue Market Share by Application (2018-2034)
Figure 40. Asia Pacific Gene Therapy Drugs Revenue Share by Region (2018-2034)
Figure 41. China Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 42. Japan Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 43. South Korea Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 44. India Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 45. Australia Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 46. China Taiwan Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 47. Indonesia Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 48. Thailand Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 49. Malaysia Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 50. Latin America Gene Therapy Drugs Revenue Market Share by Company in 2022
Figure 51. Latin America Gene Therapy Drugs Revenue Market Share by Type (2018-2034)
Figure 52. Latin America Gene Therapy Drugs Revenue Market Share by Application (2018-2034)
Figure 53. Latin America Gene Therapy Drugs Revenue Share by Country (2018-2034)
Figure 54. Mexico Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 55. Brazil Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 56. Argentina Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 57. Middle East and Africa Gene Therapy Drugs Revenue Market Share by Company in 2022
Figure 58. Middle East and Africa Gene Therapy Drugs Revenue Market Share by Type (2018-2034)
Figure 59. Middle East and Africa Gene Therapy Drugs Revenue Market Share by Application (2018-2034)
Figure 60. Middle East and Africa Gene Therapy Drugs Revenue Share by Country (2018-2034)
Figure 61. Turkey Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 62. Saudi Arabia Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 63. UAE Gene Therapy Drugs Revenue (2018-2034) & (US$ Million)
Figure 64. F. Hoffmann-La Roche AG Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 65. Novartis International AG Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 66. Gilead Sciences, Inc. Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 67. Ultragenyx Pharmaceutical,Inc. Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 68. Applied Genetic Technologies Corp Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 69. Audentes Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 70. BioMarin Pharmaceutical Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 71. Bluebird Bio Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 72. Nightstar Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 73. Sangamo Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 74. Spark Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 75. uniQure Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 76. VBL Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 77. Voyager Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed